"Just moving toward our goal—especially at such a rapid pace—is making people notice. When this happens, the term Remarkable comes to mind."
Chintu Patel
CEO
Chintu Patel
CEO
Featured Products
News Archive
2013
- Amneal Gets Approval for Generic Suboxone® (02/25/2013)
- Amneal Partners With Hanmi to Market Nexium® Alternative (01/28/2013)
2012
- Amneal Pharmaceuticals Bucks Trend and Adds U.S. Manufacturing Jobs with Major Expansion (05/15/2012)
- Amneal Upgrades Generic Metformin Family by Listening to Customers (08/06/2012)
- Amneal Launches Escitalopram Oxalate Oral Solution (03/14/2012)
- Amneal Pharmaceuticals CEO Kicks Off 2012 HIA-LI CEO Roundtable Series (02/13/2012)
2011
- Amneal Launches Felbamate Oral Suspension (12/21/2011)
- Amneal Announces Corporate Business Development Team (12/6/2011)
- Amneal Launches Fluocinolone Acetonide Family For Skin And Ear Care (11/21/2011)
- Chintu and Chirag Patel of Amneal Pharmaceuticals, LLC named Ernst & Young National Entrepreneur Of The Year® 2011 Life Sciences Award winners (11/12/2011)
- Generic Felbamate Now Available from Amneal (9/19/2011)
- Amneal Announces Four New Generic Drugs (8/2/2011)
- Amneal Announces Three New Generic Liquids (7/11/2011)
- Amneal Pharmaceuticals Executives Named Ernst & Young Entrepreneur of the Year® 2011 New Jersey Award Winners (7/5/2011)
- Amneal Receives Approval For Nitrofurantoin Oral Suspension - First Generic to Market (5/23)
- Amneal Receives FDA Approval For Indomethacin ER Capsules (3/3)
2010
- What Patients Should Know About Generic Drugs: A Resource Guide for Pharmacists (11/23)
- Amneal Pharmaceuticals to Host Grand Opening of New Glasgow, KY Distribution and Sales Center on September 27 (9/20)
- Amneal Announces FDA Approval For Spironolactone HCL Tablets(8/26)
- Amneal Pharmaceuticals Receives Five Generics Industry Awards For Customer Value and Service Excellence(7/27)
- Amneal Appoints Dr. Shankar Hariharan as Chief Scientific Officer/EVP of Specialty Pharmaceuticals(7/8)
- Amneal Receives FDA Approval for Lorazepam Oral Concentrate, USP(6/15)
- Amneal Pharmaceuticals to Expand in Glasgow(5/11)
- Amneal Receives FDA Approval for Tramadol/APAP Tablets(2/8)
2009
- Amneal Receives FDA Approval for Nizatidine Oral Solution, The First Generic Oral Solution for Axid® In The Market (12/3)
- Amneal Expands Generic Portfolio With Launch of Alprazolam ER and Benazepril HCI Tablets (6/15)
- Amneal Receives FDA Approval For Its Second Liquid Rx Product, Prednisolone Sodium Phosphate, USP (5/09)
- Amneal Receives Rare FDA Approval For Extended Phenytoin Sodium Capsules, USP (5/09)
- Amneal Successfully Completes Technology/Site Tranfers For Acebutolol And Flecainide (3/09)
2008
- Amneal Receives FDA Approval For Over-The-Counter Strength Naproxen Sodium Tablets & Caplets, USP (12/08)
- Amneal Receives FDA Approval For Its First Liquid Rx Product, Ranitidine Hydrochloride Syrup (9/08)
- Amneal Closes Purchase of Interpharm Assets (6/28)
- Amneal Receives FDA Approval Using New Electronic Filing Format (5/7)
- Amneal to Acquire Assets of Interpharm Holdings (4/24)
- Demeclocycline HCl Tabs Approved (3/31)
- Primidone Tabs Approved (3/7)
- Cyclobenzaprine HCl Tabs Approved (3/1)
2007
- Amneal Completes Acquisition of Liquid Form Generic Pharmaceuticals Manufacturing Plant (12/18)
- Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process (11/27)
- Amneal & Indoco Remedies Finalize Long Term Joint Venture to Develop and Market Generic Ophthalmic Pharmaceuticals (10/18)
- FTC Challenges Mylan's Proposed Acquisition of Merck's Generic Subsidiary (9/27)
- Amneal Pharmaceuticals Profile in Chain Drug Review (9/17)
- Amneal Announces Acquisition of Akyma Pharmaceuticals (5/31)